Trade Summary

4 days ago, Lippis Daniel J., serving as CVP, TAVR at Edwards Lifesciences Corp (EW), sold 2,038 shares at $83.49 per share, for a total transaction value of $170,160.00. Following this transaction, Lippis Daniel J. now holds 33,682 shares of EW.

This sale represents a 6.00% decrease in Lippis Daniel J.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, May 1, 2026 and publicly disclosed via SEC Form 4 filing on Monday, May 4, 2026, 3 days after the trade was made.

Edwards Lifesciences Corp operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.